Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb;44(2):366-73.
doi: 10.1128/JCM.44.2.366-373.2006.

Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens

Affiliations

Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens

Barbara Van Der Pol et al. J Clin Microbiol. 2006 Feb.

Abstract

Trichomonas vaginalis PCR using reagents from a commercially available assay for Chlamydia trachomatis and Neisseria gonorrhoeae was evaluated for detection of infection in women and men attending a sexually transmitted disease clinic. Evaluations included three primer sets, endocervical swabs, vaginal swabs and urine, and various storage conditions. The TVK3/TVK7 primer set was optimal in our hands with sensitivities ranging from 69.5 to 96.8%. In all comparisons, T. vaginalis PCR performed better than routine diagnostics using microscopy for women and culture for men (P > 0.05). The assay performed well for all sample types tested, and vaginal swabs were stable for up to 7 days at ambient temperature. Using samples prepared for, and reagents from, the C. trachomatis-N. gonorrhoeae PCR assay allowed incorporation of T. vaginalis PCR diagnosis into routine clinical testing.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Procedure for testing 96 samples for C. trachomatis, N. gonorrhoeae, and T. vaginalis using reagents from one set of Amplicor CT/NG reagents. The asterisks indicate T. vaginalis PCR deviations from the CT/NG procedure.

References

    1. Buvé, A., H. A. Weiss, M. Laga, E. Van Dyck, R. Musonda, I. Zekeng, M. Kahindo, S. Anagonou, L. Morison, N. J. Robinson, and R. J. Hayes for the Study Group on Heterogeneity of HIV Epidemics in African Cities. 2001. The epidemiology of trichomoniasis in women in four African cities. AIDS 15:S89-S96. - PubMed
    1. Chesson, H. W., J. M. Blandford, and S. D. Pinkerton. 2004. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex. Transm. Dis. 31:547-551. - PubMed
    1. Cotch, M. F., J. G. Pastorek, R. P. Nugent, S. L. Hillier, R. S. Gibbs, D. H. Martin, D. A. Eschenbach, R. Edelman, J. C. Carey, J. A. Regan, M. A. Krohn, M. A. Klebanoff, A. V. Rao, G. G. Rhoads, et al. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24:353-360. - PubMed
    1. Crucitti, T., E. Van Dyck, A. Tehe, S. Abdellati, B. Vuylsteke, A. Buve, and M. Laga. 2003. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex. Transm. Infect. 79:393-398. - PMC - PubMed
    1. Gram, I. T., M. Macaluso, J. Churchill, and H. Stalsberg. 1992. Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control 3:231-236. - PubMed

Publication types

MeSH terms